Complete Care Medical, Inc., Outlines Benefits to CarePharm, LLC from Diabetes Gold, Inc. and BioTex Labs, Inc. Pact

CarePharm to Act as Fulfillment Agent and is in Line for Prescription Referrals


HOUSTON, Sept. 7, 2005 (PRIMEZONE) -- Complete Care Medical, Inc., (Pink Sheets:CCMI), is expecting a large amount of spillover business from the joint marketing effort between BioTex, Inc. and Diabetes Gold, Inc., to be directed to CarePharm, LLC a wholly owned subsidiary of CCMI. The Diabetes Gold-BioTex marketing initiative is expected to establish 250 small independent diabetes providers by eliminating the financial barriers of entry and providing a suite of free support services to them.

According to J.P. Monteverde, CEO of CCMI, CarePharm has been selected as fulfillment agent and will ship diabetes supplies directly to the patient's homes for each of the independent diabetes providers that are established through the marketing program. "But even more important then the fulfillment business, is the great opportunity for CarePharm to enroll these same diabetes patients as mail order pharmacy patients," he said. Nearly 60% of all diabetes patients are on maintenance prescription medication and each spends, on average, more than $3,000 annually on drugs.

Through its subsidiaries, Complete Care Medical, Inc., provides patients in all 50 states with lower cost alternatives for disease management, medical supplies and prescription pharmaceuticals. In addition, Complete Care Medical's discount services and medication program offers healthcare payers, healthcare providers, healthcare professionals and patients with easy access to utilization and compliance data in order to improve patient outcomes and improve quality of life.

For more information: www.ccmedicalinc.com

Forward-Looking Statements

This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Statements in this release that are "forward-looking statements" are based on current expectations and assumptions that are subject to known and unknown risks, uncertainties or other factors which may cause actual results, performance or achievements of the Company to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Actual results could differ materially because of factors such as: the effect of general economic and market conditions, entry into markets with vigorous competition, market acceptance of new products and services, continued acceptance of existing products and services, technological shifts, and delays in product development and related product release schedules, any of which may cause revenues and income to fall short of anticipated levels.

All information in this release is as of the date of this release. The Company undertakes no duty to update any forward-looking statement to conform the statement to actual results or changes in the Company's expectations.


            

Contact Data